Abstract: The following discusses a feasibility review being carried out for the use of natural language processing in the context of capturing Model-to-Model transformations in visual models, in ...
Abstract: Various approaches already exist for identifying the Jiles-Atherton (JA) hysteresis model, typically using optimization algorithms that minimize the deviation of hysteresis curves from a ...
ME Therapeutics Holdings Inc. ("ME Therapeutics" or the "Company") (CSE: METX) (FSE: Q9T), a publicly listed biotechnology ...
Leveraging its integrated "design-synthesis-quality control" system, Creative Biolabs is overcoming bottlenecks in mRNA ...
Genespire is looking to take its single-dose gene therapy, GENE202, to the clinic by the end of 2026, where it will be evaluated as a treatment for rare metabolic disease, methylmalonic acidaemia.
COVID pivot at Davos, betting on personalised mRNA cancer therapies, new vaccine launches, and AI-led drug development to drive its next growth phase.
Johns Hopkins researchers developed lipid nanoparticles to deliver therapeutic mRNA directly to the endometrium in mice. The ...
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹?TP). The ...
At the mRNA Health conference in Berlin, enginzyme and AGC Inc. presented a scalable process to produce a key mRNA vaccine and therapy ingredient, N1-methylpseudouridine-5'-triphosphate (m¹ΨTP).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results